Affiliation:
1. Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Cairo, Egypt
2. Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
Abstract
Background:
Herbs have long been used as natural therapeutics, and recent controlled clinical studies have confirmed some of the presumed benefits. Hedera helix (ivy leaves) is a valuable common from related to the family Araliaceae. Many herbal preparations include extracts from their leaves as the principle active ingredient.
Objective:
The objective of this article is to summarize the pharmacological activities and phytochemical screening of H. helix.
Methods:
The objective of this article is to summarize the pharmacological activities and phytochemical screening of H. helix.
Results:
The all-published studies depend on isolation, identification and characterization of different active constituents of H. helix leaves followed by determination of biological activities in vivo and in vitro. Chemical screening has shown that H. helix leaves are a rich source of phytochemicals with demonstrated therapeutic activities, such as sterols, tannins, terpenoids, glycosides, phenols, emetine alkaloids, flavonoids, saponins, volatile and fixed oils, vitamins, carbohydrates, reducing sugars, and minerals. Further, studies of disease models and clinical trials have demonstrated anti-inflammatory, analgesic, cough suppressant, expectorant, anticancer, antimicrobial, anticoagulant, and smooth muscle relaxant activities.
Conclusion:
This review summarizes the bioactive constituents of H. helix leaves and their underlying pharmacological mechanisms, clinical efficacies, and safety profiles. We also suggest potential therapeutic uses for Covid-19.
Publisher
Bentham Science Publishers Ltd.
Subject
Complementary and alternative medicine,Drug Discovery
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献